Introduction {#sec1}
============

Use of organic molecules that exhibit efficient thermally activated delayed fluorescence (TADF) is recognized as a method for harnessing triplet excitons in organic light-emitting diodes (OLEDs) and, at least in principle, makes possible achievement of internal quantum efficiencies of up to 100%.^[@ref1]−[@ref4]^ TADF involves the thermal upconversion of a triplet exciton to a singlet exciton through reverse intersystem crossing (RISC), followed by emission from the singlet state. RISC is facilitated by a low difference in energy between the singlet state and the triplet state (Δ*E*~ST~) and by a large spin-orbit coupling between the states.^[@ref5],[@ref6]^

The design of purely organic TADF fluorophores has largely focused on decreasing Δ*E*~ST~, while keeping the fluorescent decay rate sufficiently high to compete with nonradiative decay routes, to increase RISC rates, and, in turn, luminescent efficiency in OLEDs. Assuming the singlet and triplet excitations are both well-approximated as transitions between the same two orbitals, Δ*E*~ST~ is equal to twice the exchange energy; this is given by the exchange integral, *J*. This can be minimized by decreasing the spatial overlap of these two relevant orbitals, typically assumed to be the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO). This is generally achieved through weakly coupled donor−acceptor architectures in which these orbitals are primarily localized on the donor and acceptor moieties, respectively.^[@ref7]^ An important consideration with this approach is that constructing a donor--acceptor molecule, in which the S~1~ state is well represented as a HOMO to LUMO intramolecular charge-transfer (CT) transition, does not guarantee that the lowest lying triplet state, T~1~, has corresponding ^3^CT character, as shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}. Due to the increased spatial overlap of the relevant orbitals, donor- or acceptor-localized excited (LE) states exhibit increased exchange energy relative to CT-type states, potentially resulting in sufficient stabilization of ^3^LE states such that T~1~ has ^3^LE character, despite S~1~ having ^1^CT character,^[@ref8]^ and in larger Δ*E*~ST~ than would be expected if both S~1~ and T~1~ shared the same CT configuration. In such a case, decreasing the HOMO--LUMO energy separation, by increasing donor or acceptor strength, while keeping the LE state energies associated with the building blocks essentially unchanged, is expected to directly decrease Δ*E*~ST~.

![Hypothetical energy-level diagram of a donor--acceptor compound. The S~1~ state is an intramolecular CT excitation from a donor-localized HOMO to an acceptor-localized LUMO (^1^CT), and the ^3^CT state is lower in energy than S~1~ by twice the exchange integral of the orbitals involved in the CT (*J*^CT^). The increased energy of the exchange integral of the acceptor LE configuration (*J*^*L*E^), attributable to higher spatial overlap of the relevant orbitals than seen for the CT configuration, stabilizes ^3^LE such that this state is lower in energy than ^3^CT and consequently is the T~1~ state.](ao-2018-019795_0002){#fig1}

Here, we report two fluorophores, in which the fluorescence is consistent with the lowest energy singlet state having CT character, whereas the triplet-state characteristics are consistent with a LE state located on the diphenyloxadiazole acceptor. Compounds utilizing the 2,5-diphenyl-1,3,4-oxadiazole acceptor that exhibit TADF have been reported, including simple D-A compounds pairing it with phenoxazine^[@ref9]^ and 5-phenyl-5,10-dihydrophenazine,^[@ref10]^ and a D~5~-A compound utilizing five carbazolyl donors.^[@ref11]^ A computational study has suggested that using the donor 9,9-dimethyl-9,10-dihydroacridine would also result in a compound exhibiting TADF.^[@ref12]^ In this study, we pair 9,9-dimethyl-9,10-dihydroacridine with 2,5-diphenyl-1,3,4-oxadiazole in **DMAC-DPO** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) and, to increase acceptor strength, a difluoro derivative, **DMAC-F**~**2**~**DPO**.^[@ref13]^

![Synthesis of Acridane-Diphenyloxadiazole Fluorophores](ao-2018-019795_0001){#sch1}

Results and Discussion {#sec2}
======================

The compounds studied, 2-(4-(9,9-dimethylacridin-10(9*H*)-yl)phenyl)-5-phenyl-1,3,4-oxadiazole (**DMAC-DPO**) and 2-(4-(9,9-dimethylacridin-10(9*H*)-yl)-3,5-difluorophenyl)-5-phenyl-1,3,4-oxadiazole (**DMAC-F**~**2**~**DPO**), are shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. They were obtained in good yield through nucleophilic aromatic substitution reaction between 9,9-dimethyl-9,10-dihydroacridine, prepared via literature methods,^[@ref14]^ and the appropriate 2-(4-fluoroaryl)-5-phenyl-1,3,4-oxadiazoles **1** and **2** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). The oxadiazoles were prepared through condensation of 4-fluorobenzoyl chloride or 3,4,5-trifluorobenzoyl chloride, respectively, with benzohydrazide to yield the corresponding *N*′-benzoylbenzohydrazide, followed, without purification, by dehydration in phosphoryl chloride, as has been reported previously for **1**.^[@ref15],[@ref16]^ The thermal stability of the compounds, an important consideration in the fabrication of devices composed of vapor-deposited thin films, was probed using thermogravimetric analysis (TGA) under a nitrogen atmosphere. **DMAC-DPO** and **DMAC-F**~**2**~**DPO** displayed similar decomposition temperatures, as determined by 5% weight loss in the TGA trace, of 319 and 321 °C, respectively (SI, [Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01979/suppl_file/ao8b01979_si_001.pdf)).

Absorption and photoluminescence spectra for **DMAC-DPO** and **DMAC-F**~**2**~**DPO** in dilute toluene solution are shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. The absorption spectra of both compounds show absorption maxima at wavelengths shorter than 300 nm (289 and 290 nm, respectively) that are attributed to π--π\* transitions localized on the DPO portion of the molecules.^[@ref17]^ A broad, weaker absorption band at wavelengths longer than 300 nm was observed for each compound, with λ~max~ at 360 nm in **DMAC-DPO** and 376 nm in **DMAC-F**~**2**~**DPO**, consistent with an intramolecular CT transition between the acridane donor and diphenyloxadiazole acceptor. The room-temperature steady-state photoluminescence spectra of the fluorophores, attributed to fluorescence, show the same broad, structureless lineshape. As with the long-wavelength absorption feature, the emission maximum is bathochromatically shifted with the stronger acceptor, from 449 nm in **DMAC-DPO** to 490 nm in **DMAC-F**~**2**~**DPO**. Similarly, from the fluorescence onsets in toluene, we estimate that the S~1~ state of **DMAC-F**~**2**~**DPO** is stabilized by 0.14 eV relative to that of **DMAC-DPO** (see [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). These observations are consistent with assignment of the S~1~ states of both compounds to intramolecular CT states, with the fluoro substituents increasing the acceptor strength in **DMAC-F**~**2**~**DPO**. This assignment is further supported by solvent-dependent measurements (see SI, [Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01979/suppl_file/ao8b01979_si_001.pdf)): for both compounds the absorption is only weakly solvent-dependent, whereas the emission is substantially red shifted, and, therefore, the Stokes shift, is significantly increased, with increasing solvent polarity, as expected for compounds in which the emissive state has a dipole moment much larger than that of the ground state.

![Room-temperature absorption (black squares) and fluorescence (red triangles) spectra in dilute toluene solution and 77 K phosphorescence spectra (blue circles) in a toluene matrix, for **DMAC-DPO** and **DMAC-F**~**2**~**DPO**.](ao-2018-019795_0006){#fig2}

###### Photophysical Properties of Acridane-Oxadiazole Emitters

                                                                    absorption[a](#t1fn1){ref-type="table-fn"}   fluorescence[a](#t1fn1){ref-type="table-fn"}   phosphorescence[b](#t1fn2){ref-type="table-fn"}                                                                      
  ----------------------------------------------------------------- -------------------------------------------- ---------------------------------------------- ------------------------------------------------- ----- ------ ------ ----------- ---------------------------------- ----------------------------------
  **DMAC-DPO**, toluene                                             289, 360                                     449                                            3.02                                              496   2.78   0.24   0.16/0.18   7.0                                [g](#t1fn7){ref-type="table-fn"}
  **DMAC-F**~**2**~**DPO**, toluene                                 290, 376                                     490                                            2.88                                              503   2.75   0.13   0.15/0.24   8.8                                179
  **DMAC-F**~**2**~**DPO**, DPEPO[h](#t1fn8){ref-type="table-fn"}   288, 370                                     495                                            2.83                                              521   2.67   0.16   0.72        [g](#t1fn7){ref-type="table-fn"}   113

At ambient temperature.

At 77 K with 500 μs delay.

Estimated from difference in onsets of fluorescence and phosphorescence.

Photoluminescence quantum yields in aerated/N~2~-sparaged solutions or for a film under a stream of N~2~.

Prompt fluorescence lifetime.

Delayed fluorescence lifetime (measured in N~2~-sparged solution; see Supporting Information).

Not determined.

12.5 wt% film spin-coated from CHCl~3~.

To assess the T~1~ energy, the photoluminescence at 77 K was collected in a toluene matrix with a 500 μs delay between excitation and data collection; these spectra are attributed to phosphorescence. In contrast to the fluorescence, the phosphorescence spectra of the two compounds are almost superimposable, indicating little sensitivity to fluorine substitution on the acceptor moiety. The T~1~ energies, estimated from the onset of phosphorescence, are 2.78 and 2.75 eV for **DMAC-DPO** and **DMAC-F**~**2**~**DPO**, respectively. Furthermore, the lineshape of the emission of both compounds resembles that of an isolated 1,3,4-diphenyloxadiazole.^[@ref17]^ The 77 K delayed emission is, therefore, assigned to emission from a T~1~ state localized on the DPO moiety, rather than (as previously predicted theoretically^[@ref12]^) a CT state with a similar origin to the S~1~ state. Due to the stabilization of S~1~ with increased acceptor strength and the largely unchanged T~1~ energy, the estimated Δ*E*~ST~ is decreased from 0.24 eV in **DMAC-DPO** to 0.13 eV in **DMAC-F**~**2**~**DPO**. Solution-state photophysical data for each compound are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

To probe whether the decreased Δ*E*~ST~ of **DMAC-F**~**2**~**DPO** would lead to TADF, the transient photoluminescence in dilute toluene solution was collected, and is shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. After sparging the solution with nitrogen gas to reduce the concentration of triplet-quenching molecular oxygen, a two-component decay is observed. The fast component, with a lifetime of τ~PF~ = 8.8 ns (see SI, [Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01979/suppl_file/ao8b01979_si_001.pdf)), and a slow component, with a lifetime of τ~DF~ = 179 μs, are assigned to prompt fluorescence and TADF, respectively. Upon equilibrating with air, the slow component disappears. Furthermore, the photoluminescent quantum yield (PLQY) increases from 0.16 in air-equilibrated solution to 0.24 upon sparging with nitrogen. In contrast, **DMAC-DPO** shows only a single, fast component in the transient fluorescence after sparging with nitrogen (see SI, [Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01979/suppl_file/ao8b01979_si_001.pdf)), and the PLQY only slightly increases, from 0.16 to 0.18. These data are consistent with a higher RISC rate in the case of **DMAC-F~2~DPO**, as expected from the lower estimate of Δ*E*~ST~ obtained.

![Time-resolved photoluminescence of **DMAC-F**~**2**~**DPO** in nitrogen-sparged solution (red) shows a two-component decay, including a long-lived component with τ = 179 μs. After aeration, the long-lived component is quenched (black).](ao-2018-019795_0004){#fig3}

To better understand the properties of the emitter in an environment more relevant to an OLED device, thin films containing **DMAC-F**~**2**~**DPO** doped at 12.5 wt % into a thin film comprised of bis(2-(diphenylphosphino)phenyl)ether oxide (DPEPO), obtained via spin-casting from chloroform in air followed by drying under high vacuum, were also photophysically characterized (See [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and SI, [Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01979/suppl_file/ao8b01979_si_001.pdf)). The ambient-temperature steady-state emission and the 77 K delayed emission are both quite similar to the corresponding spectra acquired in toluene solution, but with slight red shifts in the maxima and onsets, and a slightly larger estimated Δ*E*~ST~ value of 0.16 eV. The delayed fluorescence lifetime of 113 μs is somewhat shorter than that in toluene solution.

**DMAC-F**~**2**~**DPO** was incorporated into an OLED to assess its electroluminescent properties and to provide further evidence for T~1~-to-S~1~ upconversion. The device structure, adopted from our recent work on blue to blue-green TADF OLEDs without optimization,^[@ref18],[@ref19]^ is shown below in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a, along with chemical structures of organic materials used, and was as follows: glass/ITO/MoO~3~ (15 nm)/Poly-TriCZ (80 nm)/DPEPO:**DMAC-F**~**2**~**DPO** (25 nm, 25 wt %)/TP3PO(4 nm)/TPBi(50 nm)/LiF(1 nm)/Al(50 nm)/Ag(100 nm). The thin layer of molybdenum trioxide was evaporated as a hole-injection layer. The 80 nm thick poly-TriCZ hole-transporting layer was spin-coated (500 rpm for 60 s) from a chlorobenzene solution (10 mg mL^--1^) and thermally annealed (110 °C for 2 min) in a nitrogen-filled glovebox. The emissive layer (EML) was deposited via a co-evaporation of DPEPO, selected due to its high triplet state energy of ca. 3 eV,^[@ref20]^ and the emitter with a concentration of the latter of 25 wt %. Sequentially deposited TP3PO and TPBi were layers used as electron-transport layers. Lithium fluoride was deposited to improve the electron injection between a 50 nm thick aluminum cathode and the organic layers. A silver layer was deposited atop the aluminum to assist with the contact between the devices and the test setup. The typical OLED active area was 3.0 × 3.0 mm^2^. All thermal vacuum depositions were performed at pressures below 1.0 × 10^--7^ Torr.

![(a) Device structure, (b) electroluminescence (EL) spectrum, (c) current--voltage--luminance (*J--V--L*) characteristics, and (d) external quantum efficiency of OLED device containing **DMAC-F**~**2**~**DPO** as the emitter.](ao-2018-019795_0005){#fig4}

The electroluminescent spectrum of the OLED, shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b, matched the photoluminescent spectrum of **DMAC-F**~**2**~**DPO** in a DPEPO-doped thin film, displaying emission with λ~max~ at 494 nm and CIE coordinates of *x* = 0.22 and *y* = 0.46. Current--voltage--luminance characteristics are shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}c and indicate a turn-on voltage, corresponding to a luminance of 10 cd m^--2^, of 3.5 V. The variation of external quantum efficiency (EQE) with luminance is shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}d: at low luminance (ca. 10 cd m^--2^), the device displayed a high EQE~max~ of 21.9%, which is well above the theoretical maximum EQE for a device that converts only the singlet excitons formed directly on charge recombination into light^[@ref21]^ and provides further support that triplet excitons are upconverted to singlets through the TADF process in **DMAC-F**~**2**~**DPO**. The relatively high PLQY of the compound in the solid state ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) also contributes to the high EQE~max~. On the other hand, the device displayed significant efficiency roll-off; the EQE at a luminance of 1000 cd m^--2^ was reduced to only 6.9%. Roll-off can be influenced by a variety of factors; however, the τ~DF~ of 113 μs, which is moderately long compared to many state-of-the-art TADF emitters, is likely a major contributor in this case.^[@ref22]^ The different S~1~ and T~1~ characters in this case are expected to help facilitate RISC and TADF through increasing the spin-orbit coupling,^[@ref6]^ but the apparent value of Δ*E*~ST~ (ca. 0.16 eV in DPEPO, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) is not as low as in many recently developed chromophores.^[@ref2]^

Conclusions {#sec3}
===========

In summary, two new donor--acceptor compounds were synthesized in which the S~1~ states are characterized as intramolecular CT states, whereas the T~1~ states are characterized as LE states. Substitution of fluorine onto the acceptor stabilized the CT transition by ca. 0.14 eV with negligible effect on the T~1~ state, leading to a fluorophore that displayed TADF. Incorporation of the compound into the emissive layer OLED with a DPEPO host yielded a high external quantum efficiency at low luminance, but also large efficiency roll-off.

Experimental Section {#sec4}
====================

Materials and Methods {#sec4.1}
---------------------

All reagents were purchased from commercial sources and were used without further purification. ^1^H, ^13^C, and ^19^F NMR spectra were recorded using a Bruker Avance IIIHD 500 instrument operating at 500, 125, and 470 MHz, respectively. Chemical shifts are listed in parts per million (ppm) and were referenced using the residual nondeuterated solvent ^1^H signal or the solvent ^13^C resonance. Column chromatography was carried out using silica gel (60 Å, 40--63 μm, Sorbent) as the stationary phase. Mass spectra were measured on VG Instruments 70-SE using electron impact (EI) mode. UV--vis spectra were measured using a Cary 5000 UV--vis--NIR Spectrophotometer. Fluorescence, phosphorescence, and emission transients were collected on a Jobin Yvon Fluorolog-3 equipped with a pulsed xenon lamp, photomultiplier tube (Horiba R928), and pulsed LED excitation source (NanoLED, 336 nm). Fluorescent lifetimes were fit using DAS6 decay analysis software. Solution and solid-state absolute photoluminescence quantum yields were determined with a Quantaurus-QY C11347 spectrometer; samples were excited at 330 nm.

Synthesis {#sec5}
=========

*N*′-Benzoyl-3,4,5-trifluorobenzohydrazide {#sec5.1}
------------------------------------------

3,4,5-Trifluorobenzoyl chloride (5.0 g, 26 mmol) was added to a solution of benzohydrazide (3.5 g, 26 mmol) in THF (100 mL) under nitrogen. The reaction mixture was stirred at room temperature for 17 h. Pyridine (6.0 mL, 74 mmol) was added, and the reaction mixture was stirred for an additional 1 h. Water (300 mL) was added and a white solid precipitated, which was collected by filtration, washed with water, and dried. This compound was used for next step without further purification.

2-Phenyl-5-(3,4,5-trifluorophenyl)-1,3,4-oxadiazole (**1b**) {#sec5.2}
------------------------------------------------------------

*N*′-Benzoyl-3,4,5-trifluorobenzohydrazide (7.3 g, 25 mmol) was added into POCl~3~ (60 mL), and the reaction mixture was heated to 100 °C and stirred for 4 h. The reaction mixture was cooled to room temperature and then poured into ice water (700 mL). A white solid precipitate was collected via filtration, washed with water, and dried. The crude product was purified by silica gel column chromatography using dichloromethane/ethyl acetate (19:1) as eluent. After removal of solvent, the white solid product was recrystallized from acetone/water, collected via filtration, and dried in vacuo to yield the product as a white solid (6.5 g, 93%, two steps from benzohydrazide). ^1^H NMR (500 MHz, CDCl~3~): δ 8.13 (dd, *J* = 8.4, 1.4 Hz, 2H), 7.80 (t, *J* = 6.5 Hz, 2H), 7.61--7.54 (m, 3H). ^13^C{^1^H} NMR (125 MHz, CDCl~3~): δ 165.23, 162.13 (dd, *J*~CF~ = 5.0, 2.5 Hz), 151.68 (ddd, *J*~CF~ = 250.0, 10.0, 3.8 Hz), 142.01 (dd, *J*~CF~ = 257.5, 15.0 Hz), 132.21, 129.21, 127.05, 123.33, 119.82 (dd, *J*~CF~ = 5.0, 3.8 Hz), 111.56 (dd, *J*~CF~ = 11.3, 6.3 Hz), ^19^F NMR (376.5 MHz, CDCl~3~): δ −131.43 (m, 2F), −154.03 (m, 1F). HRMS (EI, *m*/*z*): Calcd for C~14~H~7~N~2~OF~3~ (M^+^) 276.0510; Found 276.0510. Anal. Calcd for C~14~H~7~N~2~OF~3~: C, 60.88; H, 2.55; N, 10.14. Found: C, 60.90; H, 2.73; N, 10.15.

2-(4-(9,9-Dimethylacridin-10(9*H*)-yl)phenyl)-5-phenyl-1,3,4-oxadiazole (**DMAC-DPO**) {#sec5.3}
--------------------------------------------------------------------------------------

In a round-bottom flask under nitrogen, NaH (dispersion in mineral oil, 0.55 g, 14 mmol) was added to a solution of 2-(4-fluorophenyl)-5-phenyl-1,3,4-oxadiazole^[@ref15],[@ref16]^ (1.0 g, 4.2 mmol) and 9,9-dimethyl-9,10-dihydroacridine^[@ref14]^ (0.87 g, 4.2 mmol) in anhydrous DMF (20 mL). The reaction mixture was stirred at 100 °C for 30 min. Water (50 mL) was added, and the precipitate that formed was collected by filtration, washed with water, and dried. Column chromatography was performed on the pale green crude product using dichloromethane/hexane (3:1) as the eluent. The pure product was collected and concentrated in vacuo to yield a white powder (1.1 g, 63%). ^1^H NMR (500 MHz, CDCl~3~): δ 8.43 (d, *J* = 8.0 Hz, 2H), 8.20 (d, *J* = 5.5 Hz, 2H), 7.59--7.55 (m, 5H), 7.49 (d, *J* = 7.0 Hz, 2H), 7.03--6.96 (m, 4H), 6.33 (d, *J* = 8.0 Hz, 2H) 1.72 (s, 6H). ^13^C{^1^H} NMR (125 MHz, CDCl~3~): δ 164.83, 164.03, 144.64, 140.42, 132.06, 131.88, 130.40, 129.51, 129.14, 126.98, 126.43, 125.37, 123.77, 123.61, 121.04, 114.08, 36.02, 31.16. HRMS (EI, *m*/*z*): Calcd for C~29~H~23~N~3~O (M^+^) 429.1841; Found 429.1833. Anal. Calcd for C~29~H~23~N~3~O: C, 81.09; H, 5.40; N, 9.78. Found: C, 81.15; H, 5.28; N, 9.79.

2-(4-(9,9-Dimethylacridin-10(9*H*)-yl)-3,5-difluorophenyl)-5-phenyl-1,3,4-oxadiazole (**DMAC-F**~**2**~**DPO**) {#sec5.4}
---------------------------------------------------------------------------------------------------------------

In a round-bottom flask under nitrogen, NaH (dispersion in mineral oil, 0.55 g, 14 mmol) was added to a solution of 2-phenyl-5-(3,4,5-trifluorophenyl)-1,3,4-oxadiazole (1.0 g, 3.6 mmol) and 9,9-dimethyl-9,10-dihydroacridine (0.75 g, 3.6 mmol) in anhydrous DMF (20 ml). The reaction mixture was stirred at room temperature for 30 min. Water (50 mL) was added, and the precipitate was collected by filtration, washed with water, and dried. Column chromatography was performed on the pale green crude product using dichloromethane/hexane (3:1) as the eluent. The pure product was collected and concentrated in vacuo to yield a yellow powder (1.2 g, 71%). ^1^H NMR (500 MHz, CDCl~3~): δ 8.21 (d, *J* = 6.5 Hz, 2H), 8.23 (d, *J* = 7.5 Hz, 2H), 7.62--7.54 (m, 5H), 7.12 (t, *J* = 7.0 Hz, 2H), 7.07 (t, *J* = 8.0 Hz, 2H), 6.43 (d, *J* = 8.0 Hz, 2H), 1.75 (s, 6H). ^13^C{^1^H} NMR (125 MHz, CDCl~3~): δ 165.29, 161.72 (dd, ^1^*J*~CF~ = 249 Hz, ^3^*J*~CF~ = 5.0 Hz), 162.23 (t, *J*~CF~ = 3.1 Hz), 138.66, 132.20, 131.03, 129.16, 127.01, 126.75, 125.79 (t, *J*~CF~ = 10.6 Hz), 123.20, 121.86, 120.39 (t, *J*~CF~ = 16.3 Hz), 112.77, 111.59 (d, *J*~CF~ = 26.3 Hz), 36.03, 30.50. ^19^F NMR (470 MHz, CDCl~3~): δ −112.67 (d, *J*~FH~ = 9.4 Hz). HRMS (ESI, *m*/*z*): Calcd for C~29~H~21~N~3~OF~2~ (M^+^) 465.1653; Found 465.1642. Anal. Calcd for C~29~H~21~N~3~OF~2~: C, 74.83; H, 4.55; N, 9.03. Found: C, 74.56; H, 4.81; N, 8.97.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b01979](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b01979).TGA traces; solvent-dependent absorption and fluorescence spectra; solution transient photoluminescence; spectra and transients for **DMAC-F**~**2**~**DPO** films; and ^1^H, ^13^C{^1^H}, and ^19^F NMR spectra for new compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01979/suppl_file/ao8b01979_si_001.pdf))
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